CYTK R&D to Revenue
Cytokinetics Inc · R&D to Revenue
CYTK R&D to Revenue
Latest reported461.05%period ending
CYTK FY R&D/Revenue (0.00% → 461.05%)
Latest values, visible window
High-resolution chart · PNG
CYTK r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 461.0468% | |
| 1,837.2199% | |
| 4,384.1036% | |
| 254.5915% | |
| 227.0943% | |
| 173.6602% | |
| 320.5486% | |
| 282.9593% | |
| 675.4638% | |
| 56.2905% | |
| 161.9024% | |
| 94.6442% | |
| 161.3482% | |
| 471.5306% | |
| 929.55% | |
| 1,475.0873% | |
| 48.8607% | |
| 434.38% | |
| 391.9248% | |
| 1,574.1925% | |
| 455.2289% | |
| 296.7192% | |
| 321.49% | |
| 249.4208% | |
| 247.5904% | |
| 0% |